A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

The men — Gursewak Singh Bal, Deepak Balwant Paradkar and Rolan Sokolovski — were each arrested in Ontario last week and face ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Trump administration has revealed new, lower prices for 15 widely used prescription drugs, the result of Medicare ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The second round of negotiations cuts spending an aggregate 44% over 2024 list prices as the federal government extends ...

Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, ...